Skip to main content
PMC home page
Gut logoLink to Gut
. 1999 Sep;45(3):375–381. doi: 10.1136/gut.45.3.375

Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis

F Baert 1, K Wouters 1, G D'Haens 1, P Hoang 1, S Naegels 1, F D'Heygere 1, J Holvoet 1, E Louis 1, M Devos 1, K Geboes 1
PMCID: PMC1727642  PMID: 10446105

Abstract

BACKGROUND AND AIMS—It is not known whether lymphocytic colitis and collagenous colitis represent different clinical entities or constitute part of a spectrum of disease.
METHODS—Detailed clinical features and histological findings were compared in a large series of patients with confirmed lymphocytic and collagenous colitis.
RESULTS—Histological diagnosis was confirmed in 96 patients with collagenous colitis and 80 with lymphocytic colitis. Twenty eight per cent of patients with collagenous colitis and 26% of patients with lymphocytic colitis had overlapping but less pronounced histological features. Both groups were equal in terms of age, use of aspirin and non-steroidal anti-inflammatory drugs, associated autoimmune conditions, arthritis, diarrhoea, and abdominal pain. The male:female ratio was 27:73 for collagenous colitis and 45:55 for lymphocytic colitis (p=0.013). Twenty five per cent of patients with collagenous colitis compared with 14% of patients with lymphocytic colitis were active smokers; only 8.3% of patients with collagenous colitis had stopped smoking compared with 23% of patients with lymphocytic colitis (p=0.013). Drug induced disease was suspected for ticlopidine (two collagenous colitis, four lymphocytic colitis) and flutamide (four lymphocytic colitis). Mean duration of symptoms before diagnosis was two months for lymphocytic colitis and four months for collagenous colitis. Overall prognosis was generally mild; 84% of patients with lymphocytic colitis and 74% of patients with collagenous colitis reported resolution or significant improvement (p=0.033).
CONCLUSIONS—Collagenous and lymphocytic colitis are similar but not identical. Patients with lymphocytic colitis present somewhat earlier and are less likely to be active smokers. Symptoms are milder and more likely to disappear in lymphocytic colitis. Ticlopidine and flutamide should be added to the list of drugs inducing colitis.


Keywords: lymphocytic colitis; collagenous colitis; drugs; diarrhoea

Full Text

The Full Text of this article is available as a PDF (138.2 KB).

Figure 1  .

Figure 1  

Open in a new tab

(A) Microphotograph of collagenous colitis showing clear thickening of the subepithelial collagen table, mild lamina propria inflammation, and no increase in intraepithelial lymphocytes (IELs) (haematoxylin and eosin; original magnification × 500). (B) Microphotograph of lymphocytic colitis with increase in IELs (haematoxylin and eosin; original magnification × 300). © Microphotograph of overlap form (collagenous and lymphocytic colitis) with thickening of the subepithelial collagen table, epithelial damage, and increase in IELs (haematoxylin and eosin; original magnification × 300).

Figure 2  .

Figure 2  

Open in a new tab

Age and sex distribution for lymphocytic colitis (A) and collagenous colitis (B).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaugerie L., Luboinski J., Brousse N., Cosnes J., Chatelet F. P., Gendre J. P., Le Quintrec Y. Drug induced lymphocytic colitis. Gut. 1994 Mar;35(3):426–428. doi: 10.1136/gut.35.3.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beaugerie L., Patey N., Brousse N. Ranitidine, diarrhoea, and lymphocytic colitis. Gut. 1995 Nov;37(5):708–711. doi: 10.1136/gut.37.5.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berrebi D., Sautet A., Flejou J. F., Dauge M. C., Peuchmaur M., Potet F. Ticlopidine induced colitis: a histopathological study including apoptosis. J Clin Pathol. 1998 Apr;51(4):280–283. doi: 10.1136/jcp.51.4.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bohr J., Tysk C., Eriksson S., Abrahamsson H., Järnerot G. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut. 1996 Dec;39(6):846–851. doi: 10.1136/gut.39.6.846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bohr J., Tysk C., Yang P., Danielsson D., Järnerot G. Autoantibodies and immunoglobulins in collagenous colitis. Gut. 1996 Jul;39(1):73–76. doi: 10.1136/gut.39.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bowling T. E., Price A. B., al-Adnani M., Fairclough P. D., Menzies-Gow N., Silk D. B. Interchange between collagenous and lymphocytic colitis in severe disease with autoimmune associations requiring colectomy: a case report. Gut. 1996 May;38(5):788–791. doi: 10.1136/gut.38.5.788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Giardiello F. M., Lazenby A. J., Bayless T. M., Levine E. J., Bias W. B., Ladenson P. W., Hutcheon D. F., Derevjanik N. L., Yardley J. H. Lymphocytic (microscopic) colitis. Clinicopathologic study of 18 patients and comparison to collagenous colitis. Dig Dis Sci. 1989 Nov;34(11):1730–1738. doi: 10.1007/BF01540051. [DOI] [PubMed] [Google Scholar]
  8. Giardiello F. M., Lazenby A. J., Yardley J. H., Bias W. B., Johnson J., Alianiello R. G., Bedine M. S., Bayless T. M. Increased HLA A1 and diminished HLA A3 in lymphocytic colitis compared to controls and patients with collagenous colitis. Dig Dis Sci. 1992 Apr;37(4):496–499. doi: 10.1007/BF01307569. [DOI] [PubMed] [Google Scholar]
  9. Järnerot G., Tysk C., Bohr J., Eriksson S. Collagenous colitis and fecal stream diversion. Gastroenterology. 1995 Aug;109(2):449–455. doi: 10.1016/0016-5085(95)90332-1. [DOI] [PubMed] [Google Scholar]
  10. Lazenby A. J., Yardley J. H., Giardiello F. M., Jessurun J., Bayless T. M. Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol. 1989 Jan;20(1):18–28. doi: 10.1016/0046-8177(89)90198-6. [DOI] [PubMed] [Google Scholar]
  11. Martínez Avilés P., Gisbert Moya C., Berbegal Serra J., López Benito I. Colitis linfocitaria inducida por ticlopidina. Med Clin (Barc) 1996 Mar 2;106(8):317–317. [PubMed] [Google Scholar]
  12. Mullhaupt B., Güller U., Anabitarte M., Güller R., Fried M. Lymphocytic colitis: clinical presentation and long term course. Gut. 1998 Nov;43(5):629–633. doi: 10.1136/gut.43.5.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Riddell R. H., Tanaka M., Mazzoleni G. Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis: a case-control study. Gut. 1992 May;33(5):683–686. doi: 10.1136/gut.33.5.683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Schmeck-Lindenau H. J., Kurtz W., Heine M. Lymphozytäre Colitis unter Ticlopidin. Dtsch Med Wochenschr. 1998 Apr 9;123(15):479–479. [PubMed] [Google Scholar]
  15. Thomson A. Microscopic colitis--no longer an appropriate term? Am J Gastroenterol. 1998 Apr;93(4):524–526. doi: 10.1111/j.1572-0241.1998.158_b.x. [DOI] [PubMed] [Google Scholar]
  16. Veress B., Löfberg R., Bergman L. Microscopic colitis syndrome. Gut. 1995 Jun;36(6):880–886. doi: 10.1136/gut.36.6.880. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES